EmpathBio is a biotech company dedicated to developing 3,4-Methylenedioxymethamphetamine derivatives in conjunction with digital therapeutics to deliver efficient, scalable treatments to patients on their own terms.The mental healthcare system is in desperate need of innovation.EmpathBio is focused on developing MDMA derivatives with different pharmacological profiles than MDMA. The company believes that such changes may permi...
EmpathBio is a biotech company dedicated to developing 3,4-Methylenedioxymethamphetamine derivatives in conjunction with digital therapeutics to deliver efficient, scalable treatments to patients on their own terms.The mental healthcare system is in desperate need of innovation.EmpathBio is focused on developing MDMA derivatives with different pharmacological profiles than MDMA. The company believes that such changes may permit the entactogenic effects of MDMA to be separated from some of the known adverse effects.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.